Plegridy 125 mcg/0.5 ml, Injektionslösung in einer Fertigspritze zur intramuskulären Anwendung
7680682800018
CH-68280
Injektionslösung
Associated product:
PLEGRIDY sol inj 125 mcg/0.5 ml ser pré 2 pce
1 / 3
google
Article details
- Package size
- 2
- Selling units
- 2
- Measure
- Fertigspritze(n)
- Galenic form
- Injektionslösung
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
125.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.13 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 924.15
Specialties list
Yes
Generic
No
SL addition date:
01/05/2022
Authorization holder
Biogen Switzerland AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 68280
- Drug name
- Plegridy, Injektionslösung in einer Fertigspritze zur intramuskulären Anwendung
- Galenic form
- INLFS
- ATC Code
- L03AB13
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 01/03/2022
- Authorization expiration date
- 28/02/2027
- IT Number
- 01.99.0.
- Domain
- Human medicine
Package details
- Description (FR)
- PLEGRIDY sol inj 125 mcg/0.5 ml ser pré 2 pce
- Description (DE)
- PLEGRIDY Inj Lös 125 mcg/0.5 ml Fertspr 2 Stk
- Market launch
- 01/03/2022
- Narcotic (BTM)
- No